文献速递免疫规划

去糖基化嵌合猪繁殖与呼吸综合征病毒作为疫苗候选株的体内外研究及其在商品猪生产水平的现实收益影响

In vitro and in vivo studies of deglycosylated chimeric porcine reproductive and respiratory syndrome virus as a vaccine candidate and its realistic revenue impact at commercial pig production level.
PubMed 文献 · Vaccine · 2017-08-10

本研究在嵌合PRRSV K418基础上构建去糖基化GP5的K418DM,在MARC-145细胞上传9代未发现去糖基化相关氨基酸回复突变,猪体单次传代仅检出1例回复突变。血清学显示K418DM较K418诱导更高中和抗体并限制病毒血症,临床试验中K418DM诱导的中和抗体和PRRSV特异性IgG超过保护限,经济分析显示弱猪百分比有统计学显著降低。

要点

  • K418DM在MARC-145细胞传9代无去糖基化相关GP5氨基酸回复突变,猪体单次传代检出1例回复突变。
  • K418DM较K418诱导更高的血清中和抗体和更有限的病毒血症。
  • 临床试验中K418DM诱导的中和抗体滴度和PRRSV特异性IgG超过保护限,弱猪百分比有统计学显著降低。

核心结论

  • 接种K418DM可能为PRRS流行情况下的猪提供增强的保护,并提高商品猪场的生长性能。

研究设计与样本

  • 在先前构建的嵌合PRRSV K418(ORF1来自FL12株,ORF2-7来自韩国代表性LMY株)基础上构建去糖基化糖蛋白5(GP5)的K418DM,并进行体内外病毒学与血清学检测、临床试验和经济分析。

主要发现

  • K418DM在MARC-145细胞上传9代未显示与去糖基化相关的GP5氨基酸回复突变,而在猪体单次传代后仅检出1例回复突变。
  • 血清学研究中,K418DM较K418病毒诱导更高的血清中和(SN)抗体和更有限的病毒血症。
  • 临床试验中,K418DM诱导的SN抗体滴度和PRRSV特异性IgG超过保护限。
  • 从经济角度看,弱猪百分比有统计学显著降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Porcine reproductive and respiratory syndrome virus (PRRSV) causes major economic losses in the swine industry worldwide. Vaccination is the most effective method to control the disease. In a previous study, a chimeric PRRSV named as K418 which had a genome composed of ORF 1 from the FL12 strain and ORF 2-7 from the Korean representative LMY strain was created. We constructed K418DM, K418 with deglycosylated glycoprotein 5 (GP5), to improve its humoral immunity. In the follow-up on in vivo and in vitro virological and serological tests, no back mutation in amino acids of GP5 associated with deglycosylation was shown after 9 passages on MARC-145 cells, whereas only one case of back mutation was detected after single passage in pig. In serological study, K418DM induced higher serum neutralization (SN) antibody and more limited viremia compared with those of K418 virus. In clinical trial and economic analysis, the K418DM elicited SN antibody titers and PRRSV-specific IgG over protection limit. From the economic viewpoint, there was statistically significant reduction in percentage of weak pigs. These results indicated that vaccination with the K418DM may provide enhanced protection for pigs in PRRS endemic situation and increase growth performance in commercial pig farms.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kim JJ, Lee JA, Choi HY, et al. In vitro and in vivo studies of deglycosylated chimeric porcine reproductive and respiratory syndrome virus as a vaccine candidate and its realistic revenue impact at commercial pig production level. Vaccine. 2017. PMID: 28802752. doi:10.1016/j.vaccine.2017.07.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。